CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

CaseBioscience® rejoint l'équipe qui s'est vu attribuer jusqu'à 7,3 millions de dollars par l'ARPA-H pour faire progresser la conservation à température ambiante des thérapies cellulaires

PartnershipPositive
AI Analysis

Summary

CaseBioscience joined a multidisciplinary team led by Likarda that received up to $7.3 million from ARPA-H to advance room temperature preservation of cell therapies.

Outcome Details

ARPA-H grant award of up to $7.3 million for advancing room temperature preservation of cell therapies

Importance:5/10
Sentiment:
0.60
partnershipgrant fundingcell therapyroom temperature preservationARPA-H
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on October 2, 2026 6:34 AM

Read Original